Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Parathyroid Glands00:59

The Parathyroid Glands

The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of dual-modality ablation for symptomatic cystic thyroid nodules.

Gland surgery·2026
Same author

Rare But Risky: Clinical Impacts of Pneumothorax After Thyroidectomy and Parathyroidectomy.

The Laryngoscope·2026
Same author

Beyond levothyroxine: a narrative review of adjunctive management strategies for Hashimoto's thyroiditis.

Gland surgery·2026
Same author

Impact of cervical thymectomy on multiple endocrine neoplasia type 1 patients undergoing parathyroidectomy for primary hyperparathyroidism.

Surgery·2026
Same author

[Corrigendum] Tumor necrosis factor‑α triggers opposing signals in head and neck squamous cell carcinoma and induces apoptosis via mitochondrial‑ and non‑mitochondrial‑dependent pathways.

International journal of oncology·2026
Same author

Safety and efficacy of radiofrequency ablation of benign thyroid nodules in patients with a history of implantable cardioverter defibrillators (ICDs), permanent pacemakers (PPMs), and implantable cardiac monitors (ICMs).

Gland surgery·2026
Same journal

Little Tube; Big Problems: Eustachian Tube Dysfunction.

Otolaryngologic clinics of North America·2026
Same journal

Current State of Button Battery Ingestion Injuries.

Otolaryngologic clinics of North America·2026
Same journal

Diagnostic Algorithm for Eustachian Tube Dysfunction and Indications for Balloon Dilation of the Eustachian Tube.

Otolaryngologic clinics of North America·2026
Same journal

Patulous Eustachian Tube Dysfunction.

Otolaryngologic clinics of North America·2026
Same journal

Revisiting Eustachian Tube Anatomy and Physiology.

Otolaryngologic clinics of North America·2026
Same journal

Glottic Stenosis.

Otolaryngologic clinics of North America·2026
See all related articles

Related Experiment Video

Updated: Jun 12, 2026

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging
07:12

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging

Published on: August 17, 2022

Primary hyperparathyroidism.

Erin A Felger1, Emad Kandil

  • 1Department of Surgery, Washington Hospital Center, Washington, DC 20010, USA. erin.a.felger@medstar.net

Otolaryngologic Clinics of North America
|June 1, 2010
PubMed
Summary
This summary is machine-generated.

Primary hyperparathyroidism, a common cause of hypercalcemia, is increasingly diagnosed biochemically. Advances in preoperative localization and intraoperative parathyroid hormone monitoring have improved surgical outcomes, leading to minimally invasive procedures with high patient satisfaction.

More Related Videos

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
03:57

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

Related Experiment Videos

Last Updated: Jun 12, 2026

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging
07:12

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging

Published on: August 17, 2022

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
03:57

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

Area of Science:

  • Endocrinology
  • Surgical Oncology

Background:

  • Primary hyperparathyroidism is the leading cause of hypercalcemia in outpatients.
  • The condition's presentation has shifted from overt symptoms to subtle complaints and biochemical findings.
  • Surgical management has been significantly advanced by modern techniques.

Purpose of the Study:

  • To review the evolution of primary hyperparathyroidism diagnosis and management.
  • To highlight the impact of preoperative localization and intraoperative parathyroid hormone monitoring.
  • To discuss the current trends in minimally invasive parathyroid surgery.

Main Methods:

  • Review of current literature and clinical practices in managing primary hyperparathyroidism.
  • Analysis of the role of diagnostic imaging for parathyroid adenoma localization.
  • Evaluation of intraoperative parathyroid hormone assays in guiding surgical resection.

Main Results:

  • Primary hyperparathyroidism remains the most frequent cause of hypercalcemia in ambulatory patients.
  • Diagnostic criteria have evolved towards biochemical detection over symptomatic presentation.
  • Minimally invasive parathyroidectomy is now a global standard, demonstrating reduced complications and enhanced patient contentment.

Conclusions:

  • Preoperative localization and intraoperative parathyroid hormone monitoring have transformed parathyroid surgery.
  • Minimally invasive approaches offer effective treatment with high success rates and patient satisfaction.
  • The shift towards biochemical diagnosis necessitates refined surgical strategies for primary hyperparathyroidism.